Skip to content

Author

Mafalda Oliveira

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission

Introduction HER2-targeted therapy (HER2-TT) has improved outcomes in HER2+ metastatic breast cancer (MBC) with increasing numbers of long-term survivors in complete response (CR). Little is known about discontinuing maintenance HER2-TT in these patients. Methods An online survey of physicians was conducted via the Bre...

Han-Yi Lee, W. Ong, V. Tjan-Heijnen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.